| API | Navê hilberê | DOZA NO. | Bisinifkirinî |
| HQC23838 | Sulfapyridine | 144-83-2 | Antîbiyotîk |
| PF-07321332 (dermanê Paxlovid) | (1R,2S,5S)-6,6-DIMETHYL-3-AZA-BICYCLO[3.1.0]HEXANE-2-KARBOXYL ACID METÎL ESTER HÎDROKLORID | 565456-77-1 | COVID 19 |
| PF-07321333 (dermanê Paxlovid) | L-Valine, 3-methyl-N-(trifluoroacetyl)- (9CI) | 666832-71-9 | COVID 19 |
| PF-07321334 (dermanê Paxlovid) | (αS,3S)-α-[(tert-Bûtîloksikarbonîl) aMîno]-2-okso-3-pîrrolîdînepropanoîk asîdê Methyl Ester | 328086-60-8 | COVID 19 |
| PF-07321335 (dermanê Paxlovid) | 6,6-Dimethyl-3-azabiciklo[3.1.0]hexane | 943516-54-9 | COVID 19 |
| PF-07321336 (dermanê Paxlovid) | Dimethyl (2S,4R)-2-(Boc-amino)-4-(cyanomethyl)pentanedioate | 328086-57-3 | COVID 19 |
| PF-07321337 (dermanê Paxlovid) | 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride | 25952-53-8 | COVID 19 |
| PF-07321338 (dermanê Paxlovid) | 2-Hydroxypyridine 1-oxide (HOPO) | 13161-30-3 | COVID 19 |
| PF-07321339 (dermanê Paxlovid) | Lithium hydroxide | 1310-65-2 | COVID 19 |
| PF-07321340 (dermanê Paxlovid) | 1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (HATU) | 148893-10-1 | COVID 19 |
| apixaban | Asîda acetîk, 2-chloro-2-[2-(4-metoksîfenîl)hîdrazinylidene], etîl ester | 27143-07-3 | Cardiovascular |
| apixaban | 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one | 545445-44-1 | Cardiovascular |
| Sacubitril | LCZ696 | 1426129-50-1 | Cardiovascular |
| Sacubitril | (2R,4S)-5-([1,1'-bifenîl]-4-îl)-4-((tert-butoksîkarbonîl) aMino)-2-Methylpentanoic acid | 1012341-50-2 | Cardiovascular |
| Sacubitril | AHU377 | 149709-62-6 | Cardiovascular |
| Ticagrelor | 2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioksol-4-yloksi) etanol L-tataric acid | 376608-65-0 | Cardiovascular |
| Ticagrelor | (1R,2S)-2-(3,4-Difluorofenyl)cyclopropanaminium(2R)-hîdroksî(fenîl)etanoate | 376608-71-8 | Cardiovascular |
| Ticagrelor | Cyclopropanamine, 2-(3,4-difluorofenyl)-(1R,2S) -(2R,3R)-2,3-dihydroxybutanedioate | 220352-39-6 | Cardiovascular |
| Ticagrelor | 4,6-dîchloro-2-propylthiopyrimidine-5-amine | 145783-15-9 | Cardiovascular |
| Quinapril | (S)-1,2,3,4-Tetrahydro-3-îsoquinolinecarboxylic acid | 74163-81-8 | Cardiovascular |
| Rosuvastatin | Z-9: 4-(4-Fluorofenyl)-6-Izopropil-2-[(N-methyl-N-methylsulfonyl)amino] pyrimidinyl-5-yl-formyl | 147118-37-4 | Cardiovascular |
| Rosuvastatin | Z-7: 4-(4-Fluorofenyl)-6-îsopropil-2-[(N-methyl-N-methylsufonyl)amino]pyrimidine-5-yl-metanol | 147118-36-3 | Cardiovascular |
| Rivaroxaban | 4-(4-Amînofenîl) morfolîn-3-one | 438056-69-0 | Cardiovascular |
| Rivaroxaban | 5-Klorotiofen-2-Asîda karboksîlîk | 24065-33-6 | Cardiovascular |
| Rivaroxaban | (S)-(+)-N-(2,3-Epoksîpropil)ftalîmîd | 161596-47-0 | Cardiovascular |
| Clopidogrel | Thiophene-2-etanol | 5402-55-1 | Cardiovascular |
| Clopidogrel | 4,5,6,7-Tetrahydro-thieno[3,2-c]pyridine HCl | 28783-41-7 | Cardiovascular |
| Patiromer | Methyl 2-Fluoroacrylate | 2343-89-7 | Cardiovascular |
| Ezetimibe | (3R,4S)-4-(4-(Benzîloksî)Fenîl)-1-(4-Fluorofenîl)-3-((S)-3-(4- Fluorofenîl)-3-Hîdroksîpropîl)Azetîdîn-2-One | 163222-32-0 | Cardiovascular |
| Fenofibrate | Fenofibrat acid: (2-[4-(4-chlorobenzoyl)fenoxy]-2-methylpropionic acid) | 42017-89-0 | Cardiovascular |
| Edoxaban | Etil 2-((5-chloropyridin-2-yl)amino)-2-oxoacetate hîdrochloride | 1243308-37-3 | Cardiovascular |
| Edoxaban | 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c] pyridine-2-carboxylic acid hydrochloride | 720720-96-7 | Cardiovascular |
| Edoxaban | Tert-Butyl(1R,2S,5S)-2-azido-5-[(dimethylamino)carbonyl]cyclohexylcarbamate oxalic acid | 1353893-22-7 | Cardiovascular |
| donorguat | 5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-karbonitrile | 1350653-26-7 | Cardiovascular |
| Sotagliflozin | 4-Iodo-1-chloro-2-(4-etoksîbenzîl)benzen | 1103738-29-9 | nexweşîya şekir |
| Sotagliflozin | D-xylo-Pentodialdo-5,2-furanose, 4,5-O-(1-Methylethylidene)-1-C-4-Morpholinyl-,(5S)- | 1103738-19-7 | nexweşîya şekir |
| Sotagliflozin | D-xylo-Pentodialdo-5,2-furanose, 1-C-[4-chloro-3-[(4-etoksîfenîl)Metîl]fenîl]-4,5-O-(1-Methylethylidene)-,(5S) - | 1103738-30-2 | nexweşîya şekir |
| Sotagliflozin | 5-bromo-2-kloro-4'-etoksîdîfenîlmetan | 461432-23-5 | nexweşîya şekir |
| Canagliflozin | 2-(4-FLUOROFENÎL)TÎOFEN | 58861-48-6 | nexweşîya şekir |
| Canagliflozin | 5-Bromo-2-methylbenzoic acid | 79669-49-1 | nexweşîya şekir |
